13 studies found for:    idiopathic pulmonary fibrosis | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
1 Recruiting Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
2 Recruiting Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis
Condition: IPF
Intervention:
3 Recruiting Treatment of IPF With Laparoscopic Anti-Reflux Surgery
Conditions: Idiopathic Pulmonary Fibrosis;   Gastroesophageal Reflux
Intervention: Procedure: Surgery
4 Not yet recruiting Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Healthy
Intervention:
5 Recruiting Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis;   Diffuse Parenchymal Lung Disease;   Interstitial Lung Disease
Interventions: Drug: sirolimus;   Other: Placebo
6 Recruiting Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis
Condition: Ambulatory IPF
Interventions: Drug: Rituximab;   Drug: Placebo
7 Recruiting The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease
Conditions: Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis;   Interstitial Pneumonitis;   Desquamative Interstitial Pneumonia
Intervention: Other: Aerobic Exercise Training
8 Unknown  Study of Default Options in Advance Directives
Conditions: COPD;   Severe or Very Severe Airflow Obstruction and/or Receiving or Eligible to Receive Long-term Oxygen Therapy;   Idiopathic Pulmonary Fibrosis;   Other Interstitial Lung Disease Without Curative Therapy;   Congestive Heart Failure;   NYHA Class IV or NYHA Class III Plus 1 Hospitalization in the Past Year;   Malignancy;   Any Stage 3B or 4 Solid Tumor
Interventions: Other: Comfort Default AD forms;   Other: Life Extension Default AD forms;   Other: Standard Default AD forms
9 Not yet recruiting Cromolyn Detection of Silent Aspiration
Conditions: Gastroesophageal Reflux;   Respiratory Aspiration;   Idiopathic Pulmonary Fibrosis;   Lung Transplantation
Intervention: Drug: Cromolyn Sodium
10 Recruiting Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease
Conditions: Pulmonary Fibrosis;   Lung Disease
Intervention:
11 Recruiting The Six Minute Walk Test: Influence of Patient Effort on Results and Interpretation
Condition: Each Patient Serves as His/Her Own Control.
Intervention: Behavioral: alternative instruction in exercise testing (6MWT)
12 Recruiting Natural History of Noncirrhotic Portal Hypertension
Conditions: Cystic Fibrosis;   Immunologic Deficiency Syndrome;   Turner Syndrome;   Congenital Hepatic Fibrosis;   Idiopathic Non-Cirrhotic Portal Hypertension
Intervention:
13 Recruiting Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease
Condition: BRAF V600E Mutation
Interventions: Drug: Dabrafenib Mesylate;   Drug: Trametinib Dimethyl Sulfoxide

Indicates status has not been verified in more than two years